Home > Insider Trading > Filing (0001209191-15-078180)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406338	Amit Sachdev	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Policy, Access & Value	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-10-30	700	$123.34	84,201	No	4	S	Direct
Common Stock	Disposition	2015-10-30	1,500	$124.94	82,701	No	4	S	Direct
Common Stock	Disposition	2015-10-30	2,638	$126.01	80,063	No	4	S	Direct
Common Stock	Disposition	2015-10-30	1,100	$126.61	78,963	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	882	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $123.34 (range $123.06 to $123.66).
Open market sales reported on this line occurred at a weighted average price of $124.94 (range $124.40 to $125.37).
Open market sales reported on this line occurred at a weighted average price of $126.01 (range $125.43 to $126.39).
Open market sales reported on this line occurred at a weighted average price of $126.61 (range $126.44 to $126.75).